However, more research and longer follow-up are needed to fully understand the possible risks, especially for kidney cancer.
Case reports and preliminary observational studies suggest that patients with severe insulin resistance, blunted GLP-1 receptor sensitivity, or inadequate response at 15 mg may show further metabolic benefit from doses ranging from 20-30 mg weekly under careful monitoring
GLP-1 agonists enhance insulin sensitivity, reduce appetite via central nervous system pathways, and improve cardiovascular markers through glucagon-like peptide-1 receptor activation
GCL is a heterodimeric enzyme composed of a glutamate-cysteine ligase catalytic subunit (GCLC), which confers enzymatic activity, and a glutamate-cysteine ligase modifier subunit (GCLM), which enhances GCLC efficiency and attenuates feedback inhibition by GSH
The litigation targets drugs used by more than 31 million Americans
Folic acid helps your body make red blood cells and helps all of your cells function in a healthy way
